Modified oligonucleotides generally exhibit lower yields and higher production costs due to several inherent factors:
(1) Reduced synthesis efficiency: Modified phosphoramidites are often less chemically stable and exhibit lower coupling efficiency during synthesis, resulting in decreased overall yield compared to standard oligonucleotides.
(2) More stringent purification requirements: To ensure performance and purity, modified oligonucleotides typically require advanced purification methods such as PAGE or HPLC. These processes lead to additional material loss during purification.
(3) Higher raw material costs: Specialized modified monomers and reagents are significantly more expensive - often by orders of magnitude - than standard synthesis materials.
Together, these factors contribute to the higher cost structure and reduced yield commonly associated with modified oligonucleotides.